Rabia Nagda, MD, of Texas Children’s Pediatrics, emphasizes that every environment where kids spend time should be built with fall risk in mind.
Confluence Health’s transitional care program enlists semi-retired and retired doctors to cut wait times, improve follow-up care and support care teams.
Find out how to participate in the CPT process by attending an Editorial Panel meeting or applying for a new or updated CPT code.
VeriCre™ helps overcome one of the most consequential challenges in the credentialing process—receiving verified data in applications quickly and reliably
The AMA backs bipartisan legislation to reissue 40,000 unused immigrant visas for physicians and nurses.
Giving feedback that harnesses surgical residents’ thirst for improvement is a winner at Geisinger. The approach is spreading to other specialties.
Find information about the responsibilities and terms of service for the Government Relations Advocacy Fellow (GRAF) and how to apply.
Medical students at Geisinger Commonwealth School of Medicine have a special chance to ease debt burdens and meet rural health needs. Find out how.
In residency and fellowship training, the business side of medicine often gets short shrift. Catch up on what you need to succeed in health care.
ACGME-required midyear reviews shouldn’t be taken for granted. The feedback might sting, but this is your chance to drill down for specifics.
Stay up to date on OBBBA implementation and related federal rulemaking with resources from the AMA.
Supporting the Improving Seniors’ Timely Access to Care Act, details on the FDA TEMPO model and more in the latest National Advocacy Update.
ChangeMedEd® is a national bi-annual conference that brings together innovative leaders across the medical education continuum to reimagine the way future physicians are trained. Learn more.
This two-day boot camp, April 13-14, 2026, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
Find out about the election bylaws and policies for being elected to the AMA House of Delegates.
Find out about opportunities for representation of Federation organizations in the AMA sections' annual and interim meetings.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
Recap of the joint CME education event at I-25 and a review of the strategic goals for 2025-26.
Read current and past issues of WPS Members & News Highlights for the latest information on the work being done by WPS members and its leadership.
In the news: Changes to federal vaccine recommendations, GLP-1s and obesity-related cancer risk, uterine fibroids may raise heart disease risk and more.
Review a list of USAN Council-approved stems and which chemical and/or pharmacologic parameters have been established.
Substance misuse affects millions of Americans every year. The AMA is committed to addressing the root causes of substance misuse in America.
The AMA continues to urge informed prescribing to reduce opioid-related harm and appreciates the CDC recognizes that patients require individualized care.
The AMA and AMS commended Governor Asa Hutchinson and the General Assembly for removing administrative barriers to treatment for opioid use disorder (OUD).
The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.
Get the latest FDA and CDC clarifications on opioid prescribing guidelines. Find out how AMA continues to advocate against the misapplication of CDC guideline.
Causes of surprise billing, ambulatory blood pressure monitoring and more in the latest AMA national health care advocacy news.
AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.
The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward.
Congress has put drug prices under its microscope. The scrutiny is new, but the conversation is the same: Drugmakers, pharmacy benefit managers and payers set prices but never explain how.
In actions that will save lives, New Jersey and Washington, D.C., removed prior authorization for Medicaid patients who need medication-assisted treatment.
